Kim Kyung Kyu, Kim Ja Kyung, Kim Do Young, Ahn Sang Hoon, Chon Chae Yoon, Moon Young Myoung, Chung Kyung Young, Han Kwang-Hyub
Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
Korean J Hepatol. 2005 Dec;11(4):350-8.
BACKGROUND/AIMS: Although the lung is the most common site of extrahepatic spread from hepatocellular carcinoma (HCC), the role of surgery for pulmonary metastasis remains unclear. The aim of this study was to evaluate the efficacy of pulmonary resection in patients with pulmonary metastasis from HCC.
Between July 2000 and July 2004, a total of 6 patients with pulmonary metastasis from HCC underwent curative pulmonary resections. The patients were divided into two groups (Surgery group and Non-surgery group) according to the primary treatment modality of HCC. Medical records, imaging studies, and pathologic reports of the surgical specimens were reviewed.
Three patients in the surgery group underwent pulmonary resections for a solitary metastasis after hepatectomy for HCC, and they are all still alive. One of the 3 patients developed a tumor recurrence in the chest wall after pulmonary resection. The survival time after diagnosis of HCC were 79, 122, and 54 months, respectively. The survival time after pulmonary metastatectomy were 49, 39, and 20 months in the three patients. Another 3 patients in the non-surgery group, received a pulmonary metastatectomy; they had either a complete response HCC or partial radiologic response. These 3 patients developed recurrent disease in the liver. One of 3 patients died. The survival time after diagnosis of HCC were 153, 83, 12 months. The survival time after pulmonary metastatectomy were 51, 4, 2 months.
The surgical resections of a solitary pulmonary metastasis from HCC in highly selected patients might be an effective treatment modalities for prolonged survival.
背景/目的:尽管肺是肝细胞癌(HCC)肝外转移最常见的部位,但手术治疗肺转移的作用仍不明确。本研究的目的是评估肺切除治疗HCC肺转移患者的疗效。
2000年7月至2004年7月,共有6例HCC肺转移患者接受了根治性肺切除。根据HCC的主要治疗方式将患者分为两组(手术组和非手术组)。回顾了手术标本的病历、影像学检查和病理报告。
手术组3例患者在HCC肝切除术后因孤立性转移接受了肺切除,目前均存活。3例患者中有1例在肺切除术后胸壁出现肿瘤复发。诊断HCC后的生存时间分别为79、122和54个月。3例患者肺转移切除术后的生存时间分别为49、39和20个月。非手术组的另外3例患者接受了肺转移切除术;他们的HCC要么完全缓解,要么部分影像学缓解。这3例患者肝脏出现复发性疾病。3例患者中有1例死亡。诊断HCC后的生存时间分别为153、83、12个月。肺转移切除术后的生存时间分别为51、4、2个月。
在经过严格筛选的患者中,手术切除HCC孤立性肺转移可能是延长生存期的有效治疗方式。